The anti‐inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct‐ligated rats

Abstract

The present study provides morphological and molecular biological evidences for the role of celecoxib in cholestatic liver fibrosis. Celecoxib protects against hepatic inflammation in the early stage of BDL rats, but does not have an effect on liver fibrosis.